[{"Assets_0_Q3_USD":4620840000.0,"CommonStockSharesOutstanding_0_Q3_shares":255610812.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":955708000.0,"NetIncomeLoss_1_Q3_USD":128746000.0,"NetIncomeLoss_3_Q3_USD":546369000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":259788000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":258972000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":254905000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":254096000.0,"StockholdersEquity_0_Q3_USD":2906116000.0,"EarningsPerShareBasic_1_Q3_USD":0.51,"EarningsPerShareBasic_3_Q3_USD":2.15,"EarningsPerShareDiluted_1_Q3_USD":0.5,"EarningsPerShareDiluted_3_Q3_USD":2.11,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":784535000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":2177491000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20181025"}]